4 employees
Veneno Technologies is a research and development of therapeutic disulfide-rich peptides and medicines.
2020
$1.8M
from 2 investors over 2 rounds
Veneno Technologies Co. Ltd. raised $1.8M on January 24, 2022
Investors: 筑波総研(株) and SBI Investment